Team:Shenzhen BGIC ATCG/safety

From 2013.igem.org

(Difference between revisions)
Line 73: Line 73:
<p>a.  Please  describe  the  chassis  organism(s)  you  will  be  using  for  this  project.  If  you  will  be  using  more  than  one  chassis organism, provide information on each of them:  </p>
<p>a.  Please  describe  the  chassis  organism(s)  you  will  be  using  for  this  project.  If  you  will  be  using  more  than  one  chassis organism, provide information on each of them:  </p>
<img src="https://static.igem.org/mediawiki/2013/e/eb/Safety-table1.png">
<img src="https://static.igem.org/mediawiki/2013/e/eb/Safety-table1.png">
 +
<img src="https://static.igem.org/mediawiki/2013/5/55/Safety-answer22.png">
<p>3 . List and describe  all new or modified coding regions you will be using in your project. (If you use parts from the 2013  
<p>3 . List and describe  all new or modified coding regions you will be using in your project. (If you use parts from the 2013  
iGEM Distribution without modifying them, you do not need to list  those parts.) </p>
iGEM Distribution without modifying them, you do not need to list  those parts.) </p>
 +
<img src="https://static.igem.org/mediawiki/2013/4/4f/Safety-bable2.png">
<p>4 . Do the  biological materials used in your lab work pose any of the following risks? Please describe.  </p>
<p>4 . Do the  biological materials used in your lab work pose any of the following risks? Please describe.  </p>
 +
<img src="https://static.igem.org/mediawiki/2013/c/ca/Safety-table-3.png">
<p>5 . If your project moved from a small- scale lab study to become widely used as a commercial/industrial product, what new  
<p>5 . If your project moved from a small- scale lab study to become widely used as a commercial/industrial product, what new  
risks might arise? (Consider the different categories of risks that are listed in parts a - d of the previous question.) Also, what  
risks might arise? (Consider the different categories of risks that are listed in parts a - d of the previous question.) Also, what  

Revision as of 16:20, 26 September 2013


Ball Ball

Playing with my eyes
aren't you?

Hi I am Dr. Mage!
A "budding" yeast cell!

Q & A

a. Please describe the chassis organism(s) you will be using for this project. If you will be using more than one chassis organism, provide information on each of them:

3 . List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.)

4 . Do the biological materials used in your lab work pose any of the following risks? Please describe.

5 . If your project moved from a small- scale lab study to become widely used as a commercial/industrial product, what new risks might arise? (Consider the different categories of risks that are listed in parts a - d of the previous question.) Also, what risks might arise if the knowledge you generate or the met hods you develop became widely available? (Note: This is meant to be a somewhat open - ended discussion question.)

6 . Does your project include any design features to address safety risks? (For example: kill switches, auxotrophic chassis, etc.) Note that including such features is not mandatory to participate in iGEM, but many groups choose to include them.

7 . What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.

8.Under what biosafety provisions will / do you work?